MedTrace Logo

sTMS for Substance Use-disordered Veterans

NCT04336293 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-01-17

No results posted yet for this study

Summary

The purpose of this study is to determine if synchronized transcranial magnetic stimulation is safe and tolerable in individuals with cocaine, opioid, or alcohol use disorders.

Conditions

Interventions

DEVICE

sTMS

sTMS will be delivered following NeoSync guidelines using the device user manual

DEVICE

sham sTMS

sham sTMS will be delivered following NeoSync guidelines using the device user manual

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • John E McGeary, PhD · Providence VA Medical Center, Providence, RI

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-07
Primary Completion
2023-10-31
Completion
2023-12-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04336293 on ClinicalTrials.gov